CRISPR-based tools can’t easily access the DNA in these organelles, but researchers are finding other ways in.
On June 28, 2012, the most significant scientific breakthrough of the first quarter of the 21st century was announced to the ...
Attempting to cash in on what's likely to be a relatively short-lived mania isn't a good idea for most investors most of the ...
From the 2010s to the present, the existing technologies in the clinic and operating room have been improved with the goals ...
India's biotech boom, challenges, and strategic priorities for future growth in healthcare and life sciences discussed by ...
The total market capitalization of China’s publicly listed biotech firms has reached $1.5 trillion, second only to that of the United States. As China surges, many traditional American strengths have ...
Modern medicine can mend bones, replace organs and extend life — but what does it do for the human spirit? In her new column, ...
The Cool Down on MSN
Researchers develop tiny solution for major threat to honeybees: 'Nutritionally complete'
Researchers at the University of Oxford developed a honeybee supplement to help reverse the alarming decline of honeybee ...
CRISPR Therapeutics (CRSP) has filed a prospectus supplement with the U.S. SEC to sell up to $600 million worth of its common ...
One of the most revolutionary tools in cutting-edge medicine is a molecular scalpel so precise that it can modify defective ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback